Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors

European Journal of Medicinal Chemistry
2012.0

Abstract

A series of arylalkanol-piperidine derivatives was synthesized, and their triple reuptake inhibition and in vivo activities have been evaluated. Among them, compounds 2a, 2j, 2k, 2m and 2n exhibited high potency for 5-HT, NA and DA transporters. Optimized compounds 2j and 2m showed significant reduction of immobility time compared to that of vehicle in the mouse tail suspension test (TST) test at doses ranging from 10 to 50 mg/kg po, and were not generally motor stimulants at 50 mg/kg dose. In addition, compounds 2j and 2m displayed desirable pharmacokinetic properties in SD rats.

Knowledge Graph

Similar Paper

Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors
European Journal of Medicinal Chemistry 2012.0
Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors
Bioorganic & Medicinal Chemistry Letters 2014.0
Synthesis and antidepressant effect of novel aralkyl piperazine and piperidine derivatives targeting SSRI/5-HT1A/5-HT7
Bioorganic & Medicinal Chemistry Letters 2019.0
Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT 1A /5-HT 7
European Journal of Medicinal Chemistry 2018.0
Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors
European Journal of Medicinal Chemistry 2014.0
Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis and Pharmacological Characterization of Bicyclic Triple Reuptake Inhibitor 3-Aryl Octahydrocyclopenta[c]pyrrole Analogues
Journal of Medicinal Chemistry 2011.0
Synthesis, Potency, and in Vivo Evaluation of 2-Piperazin-1-ylquinoline Analogues as Dual Serotonin Reuptake Inhibitors and Serotonin 5-HT<sub>1A</sub>Receptor Antagonists
Journal of Medicinal Chemistry 2009.0